ADA-friendly PDF: Treatment Guidelines: Adjuvant Ribociclib for Early-Stage Hormone Receptor-Positive Breast Cancer

Adjuvant Ribociclib for Early-Stage Hormone Receptor-Positive Breast Cancer

Back to Symposium

The Breast Oncology Center at Dana-Farber Brigham Cancer Center held multidisciplinary meetings to discuss recommendations regarding the use of adjuvant ribociclib in patients with early-stage hormone receptor-positive breast cancer.